166 related articles for article (PubMed ID: 31347769)
1. Very late relapse cases of TCF3-ZNF384-positive acute lymphoblastic leukemia.
Nishimura A; Hasegawa D; Hirabayashi S; Kanabuchi S; Yamamoto K; Aiga S; Nishitani M; Hosoya Y; Noguchi Y; Ohki K; Kiyokawa N; Mori S; Manabe A
Pediatr Blood Cancer; 2019 Nov; 66(11):e27891. PubMed ID: 31347769
[No Abstract] [Full Text] [Related]
2. Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia.
Oberley MJ; Gaynon PS; Bhojwani D; Pulsipher MA; Gardner RA; Hiemenz MC; Ji J; Han J; O'Gorman MRG; Wayne AS; Raca G
Pediatr Blood Cancer; 2018 Sep; 65(9):e27265. PubMed ID: 29797659
[TBL] [Abstract][Full Text] [Related]
3. ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.
Hirabayashi S; Ohki K; Nakabayashi K; Ichikawa H; Momozawa Y; Okamura K; Yaguchi A; Terada K; Saito Y; Yoshimi A; Ogata-Kawata H; Sakamoto H; Kato M; Fujimura J; Hino M; Kinoshita A; Kakuda H; Kurosawa H; Kato K; Kajiwara R; Moriwaki K; Morimoto T; Nakamura K; Noguchi Y; Osumi T; Sakashita K; Takita J; Yuza Y; Matsuda K; Yoshida T; Matsumoto K; Hata K; Kubo M; Matsubara Y; Fukushima T; Koh K; Manabe A; Ohara A; Kiyokawa N;
Haematologica; 2017 Jan; 102(1):118-129. PubMed ID: 27634205
[TBL] [Abstract][Full Text] [Related]
4. p16 inactivation associated with aggressive clinical course and fatal outcome in TEL/AML1-positive acute lymphoblastic leukemia.
Papadhimitriou SI; Polychronopoulou S; Tsakiridou AA; Androutsos G; Paterakis GS; Athanassiadou F
J Pediatr Hematol Oncol; 2005 Dec; 27(12):675-7. PubMed ID: 16344676
[TBL] [Abstract][Full Text] [Related]
5. Effective treatment with imatinib for acute B-lymphoblastic leukaemia with EBF1-PDGFRB fusion.
Horiuchi M; Yoshida M; Yamasaki K; Sakagami R; Aoyama T; Tatsumi N; Tsutsumi M; Nakaya Y; Fuseya H; Yoshimura T; Hayashi Y; Nakao T; Yamane T
Ann Hematol; 2021 May; 100(5):1329-1331. PubMed ID: 33150465
[No Abstract] [Full Text] [Related]
6. SNX2-ABL1-positive acute lymphoblastic leukemia possibly has a poor prognosis.
Mu Q; Guo L; Hu Y; Sheng L; Zhang Y; Wu N; Chen Y; Shi C; Shi S; Wu Y; Ouyang G
Leuk Lymphoma; 2017 Sep; 58(9):1-3. PubMed ID: 28278724
[No Abstract] [Full Text] [Related]
7. Allogeneic haematopoietic stem cell transplantation for infant acute lymphoblastic leukaemia with KMT2A (MLL) rearrangements: a retrospective study from the paediatric acute lymphoblastic leukaemia working group of the Japan Society for Haematopoietic Cell Transplantation.
Kato M; Hasegawa D; Koh K; Kato K; Takita J; Inagaki J; Yabe H; Goto H; Adachi S; Hayakawa A; Takeshita Y; Sawada A; Atsuta Y; Kato K
Br J Haematol; 2015 Feb; 168(4):564-70. PubMed ID: 25302748
[TBL] [Abstract][Full Text] [Related]
8. Retrospective comparison of qualitative and quantitative reverse transcriptase polymerase chain reaction in diagnosing and monitoring the ALL1-AF4 fusion transcript in patients with acute lymphoblastic leukaemia.
Elia L; Gottardi E; Floriddia G; Grillo R; Ciambelli F; Luciani M; Chiusolo P; Invernizzi R; Meloni G; Foà R; Saglio G; Cimino G
Leukemia; 2004 Nov; 18(11):1824-30. PubMed ID: 15318246
[TBL] [Abstract][Full Text] [Related]
9. Lymphoblastic lymphoma with mature b-cell immunophenotype and MLL-AF9 in a child.
Takachi T; Iwabuchi H; Imamura M; Imai C
Pediatr Blood Cancer; 2011 Dec; 57(7):1251-2. PubMed ID: 21681937
[No Abstract] [Full Text] [Related]
10. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
[TBL] [Abstract][Full Text] [Related]
11. MRD analysis and treatment outcome in three children with SET-NUP214-positive hematological malignancies.
Li WJ; Cui L; Gao C; Zhao XX; Liu SG; Xing YP; Zhang RD; Zhang DW; Wang B; Li ZG; Wu MY
Int J Lab Hematol; 2011 Dec; 33(6):e25-7. PubMed ID: 21679311
[No Abstract] [Full Text] [Related]
12. Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia.
Spinelli O; Peruta B; Tosi M; Guerini V; Salvi A; Zanotti MC; Oldani E; Grassi A; Intermesoli T; Micò C; Rossi G; Fabris P; Lambertenghi-Deliliers G; Angelucci E; Barbui T; Bassan R; Rambaldi A
Haematologica; 2007 May; 92(5):612-8. PubMed ID: 17488684
[TBL] [Abstract][Full Text] [Related]
13. The prognostic role of E2A-PBX1 expression detected by real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) in B cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
Hong Y; Zhao X; Qin Y; Zhou S; Chang Y; Wang Y; Zhang X; Xu L; Huang X
Ann Hematol; 2018 Sep; 97(9):1547-1554. PubMed ID: 29705861
[TBL] [Abstract][Full Text] [Related]
14. Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.
Bolufer P; Barragán E; Verdeguer A; Cervera J; Fernández JM; Moreno I; Lerma E; Esquembre C; Tasso M; Fuster V; Bermúdez M; Sanz MA
Haematologica; 2002 Jan; 87(1):23-32. PubMed ID: 11801462
[TBL] [Abstract][Full Text] [Related]
15. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
[TBL] [Abstract][Full Text] [Related]
16. Acute lymphoblastic leukemia in children: an update of clinical, biological, and therapeutic aspects.
Miller DR; Miller LP
Crit Rev Oncol Hematol; 1990; 10(2):131-64. PubMed ID: 2193648
[No Abstract] [Full Text] [Related]
17. Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association.
Uderzo C; Valsecchi MG; Bacigalupo A; Meloni G; Messina C; Polchi P; Di Girolamo G; Dini G; Miniero R; Locatelli F
J Clin Oncol; 1995 Feb; 13(2):352-8. PubMed ID: 7844596
[TBL] [Abstract][Full Text] [Related]
18. Clonotypic analysis of acute lymphoblastic leukemia with a double TEL-AML1 fusion at onset and relapse.
Inukai T; Yokota S; Okamoto T; Nemoto A; Akahane K; Takahashi K; Sato H; Goi K; Nakazawa S; Sugita K
Leukemia; 2006 Feb; 20(2):363-5. PubMed ID: 16357830
[No Abstract] [Full Text] [Related]
19. t(1;9)(p34;q34)/SFPQ-ABL1 Fusion in a Patient with Ph-Like Common B-Cell Acute Lymphoblastic Leukemia.
Sheng G; Zeng Z; Pan J; Wang Q; Yao H; Wen L; Ma L; Wu D; Chen S
Acta Haematol; 2017; 137(1):40-43. PubMed ID: 27894117
[No Abstract] [Full Text] [Related]
20. TLS/FUS-ERG fusion gene in acute lymphoblastic leukemia with t(16;21)(p11;q22) and monitoring of minimal residual disease.
Kanazawa T; Ogawa C; Taketani T; Taki T; Hayashi Y; Morikawa A
Leuk Lymphoma; 2005 Dec; 46(12):1833-5. PubMed ID: 16263589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]